Literature DB >> 8145851

Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.

C Hannum1, J Culpepper, D Campbell, T McClanahan, S Zurawski, J F Bazan, R Kastelein, S Hudak, J Wagner, J Mattson.   

Abstract

The FLT3/FLK2 receptor tyrosine kinase is closely related to two receptors, c-Kit and c-Fms, which function with their respective ligands, Kit ligand and macrophage colony-stimulating factor to control differentiation of haematopoietic and non-haematopoietic cells. FLT3/FLK2 is thought to be present on haematopoietic stem cells and found in brain, placenta and testis. We have purified to homogeneity and partially sequenced a soluble form of the FLT3/FLK2 ligand produced by mouse thymic stromal cells. We isolated several mouse and human complementary DNAs that encode polypeptides with identical N termini and different C termini. Some variants contain hydrophobic transmembrane segments, suggesting that processing may be required to release soluble ligand. The purified ligand enhances the response of mouse stem cells and a primitive human progenitor cell population to other growth factors such as interleukins IL-3 and IL-6 and to granulocyte-macrophage colony-stimulating factor, and also stimulates fetal thymocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145851     DOI: 10.1038/368643a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  73 in total

1.  Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD.

Authors:  Jennifer L Rocnik; Rachel Okabe; Jin-Chen Yu; Benjamin H Lee; Neill Giese; David P Schenkein; D Gary Gilliland
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

2.  RTKdb: database of Receptor Tyrosine Kinase.

Authors:  Julien Grassot; Guy Mouchiroud; Guy Perrière
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 3.  Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation.

Authors:  Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

Review 4.  Clinical significance of FLT3 in leukemia.

Authors:  Hitoshi Kiyoi; Masamitsu Yanada; Kazutaka Ozekia
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

Review 5.  Recent advances and novel agents for FLT3 mutated acute myeloid leukemia.

Authors:  Rahul Pawar; Omar Preet Singh Bali; Bharat Kumar Malhotra; Gurpreet Lamba
Journal:  Stem Cell Investig       Date:  2014-03-20

6.  Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.

Authors:  Gang G Wang; Martina P Pasillas; Mark P Kamps
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

7.  An allelic series of mutations in the kit ligand gene of mice. I. Identification of point mutations in seven ethylnitrosourea-induced Kitl(Steel) alleles.

Authors:  S Rajaraman; W S Davis; A Mahakali-Zama; H K Evans; L B Russell; M A Bedell
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

Review 8.  Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens.

Authors:  Keith Pratz; Mark Levis
Journal:  Leuk Lymphoma       Date:  2008-05

9.  Mouse mesenchymal stem cells can support human hematopoiesis both in vitro and in vivo: the crucial role of neural cell adhesion molecule.

Authors:  Xiaoli Wang; Hiroko Hisha; Tomomi Mizokami; Wenhao Cui; Yunze Cui; Aiping Shi; Changye Song; Satoshi Okazaki; Qing Li; Wei Feng; Junko Kato; Susumu Ikehara
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

10.  Flt3-L increases CD4+CD25+Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and -challenged mice.

Authors:  Halvor S McGee; Jehad H Edwan; Devendra K Agrawal
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-15       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.